Grandem for abdomina pain

Reading File

Finding Sources

Searching the Web

Grandem granisetron abdominal pain use indication dosage

Reading File

Finding Sources

Reading File

Here is a full overview of Grandem (Granisetron) for abdominal pain/nausea-vomiting:

Grandem (Granisetron) - Overview

Grandem is a brand name for Granisetron, a selective 5-HT3 receptor antagonist used primarily as an antiemetic. It is NOT a primary treatment for abdominal pain itself, but is used to manage nausea and vomiting that accompanies abdominal conditions or that results from chemotherapy, surgery, or radiation.

Mechanism of Action

Granisetron works by blocking serotonin (5-HT3) receptors at two levels:

Centrally - in the vomiting center and chemoreceptor trigger zone (CTZ) of the brain
Peripherally - on extrinsic intestinal vagal and spinal afferent nerves

This dual blockade prevents the signaling cascade that triggers nausea and vomiting. It does NOT affect dopamine or muscarinic receptors. It may slow colonic transit but does not significantly alter gastric motility.

Katzung's Basic and Clinical Pharmacology, 16th Edition

Clinical Indications

Indication	Details
Chemotherapy-induced nausea & vomiting (CINV)	Primary use - most effective agent for acute CINV
Postoperative nausea & vomiting (PONV)	Prevention and treatment after surgery
Post-radiation nausea & vomiting	Used in patients receiving radiotherapy
Nausea associated with abdominal conditions	Adjunct relief of nausea (not direct pain treatment)

Dosage

For nausea & vomiting (adults):

Route	Dose	Timing
Oral	2 mg once daily OR 1 mg twice daily	1 hour before chemotherapy
IV	1 mg (10-40 mcg/kg) slow IV injection over 30 seconds	30 min before chemotherapy
Transdermal patch	Sancuso patch applied 24-48 hrs before chemo	Replaced every 7 days

Katzung's Basic and Clinical Pharmacology, 16th Edition
Lippincott Illustrated Reviews: Pharmacology

Important Pharmacokinetics

Half-life: 4-9 hours (first-generation agent)
Metabolism: Extensive hepatic metabolism
Excretion: Renal and hepatic
Dose adjustment: NOT required in elderly or renal insufficiency patients; may be needed in hepatic insufficiency
Renal safety: Safe to use without dose modification - Comprehensive Clinical Nephrology, 7th Edition

Key Points for Abdominal Pain Context

Granisetron addresses nausea and vomiting that often accompanies abdominal pain - it does not treat the underlying cause of pain directly
It is effective for vagal-stimulation-related emesis (e.g., post-surgical abdominal pain, bowel obstruction-related nausea)
It is NOT effective for motion sickness (acts differently than antihistamines)
Efficacy is enhanced when combined with dexamethasone or NK1 receptor antagonists (like aprepitant) in chemotherapy settings

Side Effects

Headache (most common)
Constipation (slows colonic transit)
QT prolongation (cardiovascular monitoring needed at high doses)
Serotonin syndrome risk when combined with serotonergic drugs

Contraindications / Cautions

Caution with apomorphine (can cause profound hypotension and loss of consciousness)
Monitor levels of theophylline, phenytoin, or warfarin if used concurrently
Avoid in patients with known hypersensitivity

Bottom line: Grandem (Granisetron) is an effective antiemetic for nausea and vomiting associated with abdominal conditions, chemotherapy, or surgery - but if a patient has abdominal pain as the primary complaint, the underlying cause must be investigated and treated separately. Granisetron provides symptomatic relief of nausea/vomiting, not analgesia.

For abdominl che

Finding Sources

Reading File

Finding Sources

Searching the Web

drugs for abdominal ache pain antispasmodic analgesic treatment overview

Reading File

Here is a comprehensive overview of drugs used for abdominal ache (abdominal pain):

Drugs for Abdominal Ache (Abdominal Pain)

Abdominal ache is a symptom, not a diagnosis. Treatment depends on the cause. Below are the main drug categories used:

1. Antispasmodics (Most Common for Abdominal Cramps/Ache)

These relax smooth muscle in the GI tract and are the first-line agents for functional abdominal pain and cramping.

Drug	Mechanism	Use	Side Effects
Dicyclomine	Antimuscarinic - decreases GI spasms and motility	IBS-C and IBS-D, abdominal cramps	Drowsiness, dry mouth, blurred vision
Hyoscyamine	Antimuscarinic - decreases GI spasms and motility	IBS, colicky pain	Anticholinergic effects; overdose may cause hallucinations, arrhythmias
Hyoscine butylbromide (Buscopan)	Anticholinergic smooth muscle relaxant	GI/biliary/renal colic	Dry mouth, tachycardia
Mebeverine	Direct smooth muscle relaxant	IBS-related pain	Minimal side effects
Peppermint oil	Calcium channel blockade (menthol) - antispasmodic	IBS, functional bloating	GI irritation

Lippincott Illustrated Reviews: Pharmacology
Sleisenger and Fordtran's Gastrointestinal and Liver Disease

2. Analgesics

Used for moderate-to-severe abdominal pain when a cause is identified:

Drug	Use	Notes
Paracetamol (Acetaminophen)	Mild-to-moderate abdominal pain	Safe first-line option
NSAIDs (ibuprofen, diclofenac)	Inflammatory causes (e.g., dysmenorrhea, mild peritonitis)	Avoid in peptic ulcer disease, renal impairment
Opioids (morphine, tramadol)	Severe acute abdominal pain (post-diagnosis)	Risk of masking signs; use cautiously

Note: There is a historical concern about using opioids in undiagnosed acute abdominal pain as they may mask signs of a surgical emergency. However, current evidence supports appropriate analgesia even before definitive diagnosis.

3. Proton Pump Inhibitors / Antacids (for Gastric/Peptic Causes)

Drug	Use
Omeprazole, Pantoprazole (PPIs)	Peptic ulcer disease, GERD-related pain
Antacids (aluminum hydroxide, magnesium hydroxide)	Acid-related epigastric ache
H2 blockers (ranitidine, famotidine)	Gastric acid reduction

4. IBS-Specific Agents (for Functional Abdominal Pain)

Drug	Indication	Mechanism
Linaclotide / Plecanatide	IBS-C with pain	Guanylate cyclase-C agonist
Lubiprostone	IBS-C in women	Chloride channel activator
Alosetron	Severe IBS-D in women	5-HT3 antagonist
Eluxadoline	IBS-D	μ-Opioid receptor agonist
Rifaximin	IBS-D (short-term)	Non-absorbable antibiotic, reduces bacterial load

Lippincott Illustrated Reviews: Pharmacology

5. Antiemetics (for Associated Nausea/Vomiting)

Drug	Use
Metoclopramide	Nausea + pain from gastric causes, promotes motility
Ondansetron / Granisetron (Grandem)	Nausea/vomiting associated with abdominal pain
Domperidone	Gastroparesis-related abdominal pain

6. Antibiotics (for Infective Causes)

Drug	Use
Metronidazole + Cephalosporins	Peritonitis, abscess
Ciprofloxacin	Enteric infections
Rifaximin	IBS-D, small intestinal bacterial overgrowth (SIBO)

Key Principle

Abdominal ache should be assessed properly before treatment. Antispasmodics (dicyclomine, hyoscyamine, buscopan) are the most commonly used drugs for functional/colicky abdominal pain. For acute, severe, or unexplained abdominal pain - always investigate the cause first (surgical emergencies like appendicitis, obstruction, perforation must be ruled out).

Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Mayo Clinic - Antispasmodics for abdominal pain

Epigastric umbilical cord

Finding Sources

Reading File

Finding Sources

Reading File

Here is a comprehensive overview of Epigastric and Umbilical Hernias:

Epigastric and Umbilical Hernias

UMBILICAL HERNIA

Definition & Anatomy

Any hernia appearing at or closely related to the umbilicus is called an umbilical hernia. It results from failure of the umbilical ring to close, leaving a defect in the linea alba covered by normal umbilical skin.

Four Varieties

Type	Description	Key Features
1. Exomphalos	Abdominal contents protrude into umbilical cord, covered by transparent (diaphanous) membrane	Congenital; contents visible through membrane
2. Congenital umbilical hernia	Through central weak umbilical scar; seen in first months after birth	Common in Negroes; wide neck; ~90% resolve spontaneously by age 5
3. Acquired umbilical hernia	Adults; protrudes through umbilical scar due to raised intra-abdominal pressure	Causes: pregnancy, ascites, bowel distension, ovarian cyst, fibroids
4. Para-umbilical hernia	Most common acquired type; defect just ABOVE umbilicus in linea alba	Obese middle-aged women; pain + swelling; contents = omentum or bowel; often irreducible

Clinical Features (Para-umbilical - most common)

Middle-aged, obese women
Main symptoms: pain and swelling
Firm when contains omentum; soft and resonant with bowel
Many become irreducible when contents adhere to sac
Strangulation not common but possible
Incarceration presents as: abdominal pain + bilious emesis + tender hard umbilical mass (surgical emergency!)

Treatment

Children (<1 cm): Watchful waiting; most close spontaneously by age 4-5 years
Surgical repair indicated if: age >5 years without closure, symptomatic, large, incarcerated
Operative technique:
- Curved incision at umbilicus crease
- Sac dissected free from overlying skin
- Fascial defect closed with interrupted permanent/long-lasting absorbable sutures in transverse plane
- Subcuticular skin closure
- For defects >2 cm or high recurrence risk: mesh repair preferred
Schwartz's Principles of Surgery, 11th Edition
S Das Manual on Clinical Surgery, 13th Edition

EPIGASTRIC HERNIA

Definition

A protrusion of extra-peritoneal fat and sometimes a small peritoneal sac through a defect in the linea alba, located anywhere between the xiphisternum and the umbilicus.

Key Clinical Features

Main symptom: epigastric pain and swelling
Pain is located directly over the hernia
Often begins after eating (due to epigastric distension)
Patients often self-diagnose as peptic ulcer disease (because the lump may be too small to notice)
Important tip: Always palpate the abdominal wall in any patient with epigastric discomfort to detect a small epigastric hernia lump
Usually no impulse on coughing and cannot be reduced (unlike other hernias)
Differential diagnosis: Lipoma (but epigastric hernia cannot be moved over underlying structures)

Treatment

Small defects (<2 cm): Primary suture repair
- Vertical incision over palpable defect
- Herniated pre-peritoneal fat dissected and reduced (or transected at level of fascia)
- Fascia reapproximated with interrupted slowly absorbable or permanent suture
Larger defects (>2 cm) or high recurrence risk: Mesh-based repair preferred
Fischer's Mastery of Surgery, 8th Edition
S Das Manual on Clinical Surgery, 13th Edition

MESH REPAIR (Both Umbilical & Epigastric)

Mesh reduces recurrence rates even for defects as small as 1 cm. Three positions for mesh placement:

Position	Details
Onlay	Placed on top of fascia; creates large subcutaneous flaps (increased infection risk)
Preperitoneal	Between fascia and peritoneum - preferred; intra-abdominal pressure keeps mesh in place without fixation sutures
Intraperitoneal	Requires antiadhesive barrier-coated mesh (to prevent bowel adhesions)

Use permanent synthetic mesh (polypropylene) for clean cases
If mesh contacts viscera: must use antiadhesive barrier-coated mesh
Fischer's Mastery of Surgery, 8th Edition

Quick Comparison

Feature	Umbilical Hernia	Epigastric Hernia
Location	At umbilicus	Between xiphisternum and umbilicus
Contents	Bowel, omentum	Pre-peritoneal fat (mainly)
Reducibility	Often reducible	Usually NOT reducible
Cough impulse	Present	Often absent
Common patient	Children, obese adults	Adults (any)
Risk	Incarceration/strangulation	Mistaken for peptic ulcer

This is a shared conversation. Sign in to Orris to start your own chat.